Apr 15, 2020
ICBII Announces the Approval of its latest patent on Blood-Brain Barrier Permeable Technology accelerating the company's progress towards treating Neuro-Degenerative Alzheimer's and Parkinson's Diseases.
Mar 12, 2020
Global CNS Drug Delivery Market Insights & Outlook, 2017-2028 - Cell & Gene Therapies Will Play an Important Role in the Treatment of Neurological Disorders in the Future
Jan 13, 2020
Growing Demand for Novel Drug Delivery Technologies that Allow Medication to Cross the Blood Brain Barrier
Dec 17, 2019
Drug Delivery Across Blood Brain Barrier Market Worth $4.6 Billion by 2026
Dec 03, 2019
Focused Ultrasound May Open Door to Alzheimer's Treatment
Oct 15, 2019
Unlocking the Blood-Brain-Barrier: A new simple and innovative way of delivering therapeutics to brain
Aug 12, 2019
Global Central Nervous System Diseases Drug Delivery Markets, 2017-2019 & 2019-2023 & 2028
May 24, 2019
Central Nervous System Diseases Drug Delivery Markets, 2028
May 21, 2019
Global Gene Therapy Companies, Technologies, & Markets, 2018-2019 & 2028: Focus on Genetic Disorders, Cancer, Neurological Disorders, Cardiovascular Disorders, & Viral Infections
May 16, 2019
Cerebral Therapeutics(TM) to Present Clinical Data at Antiepileptic Drug and Device Trials XV Conference
May 13, 2019
Ben-Gurion University Introduces Novel Combination Therapy for Treating Neurological Disorders
Feb 14, 2019
BioArctic - Full Year Report January - December 2018
Feb 13, 2019
The National Research Council of Canada and Aspect Biosystems work toward new ways to deliver therapeutics to the brain, the holy grail of biopharmaceutical sciences
Feb 04, 2019
Global Central Nervous System Diseases Drug Delivery Report 2019: Profiles of 72 Companies with Their Technologies, Products and 100 Collaborations
Jan 04, 2019
KalGene Appoints James E. Callaway, Ph.D. as Chief Executive Officer
Dec 11, 2018
Vect-Horus Announces Agreement With Johnson & Johnson Innovation
Oct 30, 2018
HKBU's New Nanomaterial Could Enable Early Detection and Diagnosis of Alzheimer's Disease
Sep 13, 2018
Schizophrenia Breakthrough Discovered at Neuroscience Research Australia (NeuRA)
Aug 02, 2018
ArmaGen Receives U.S. Orphan Drug Designation for AGT-184
Jul 25, 2018
INSIGHTEC Receives FDA Approval to Initiate Clinical Study of MR-Guided Focused Ultrasound to Treat Patients With Alzheimer's Disease